Allegheny Health Network
Find a
Request An Appointment Login to
News Classes &
Call 412.Doctors

Liver Transplant and Hepatology Program

Allegheny Health Network provides expertise for a variety of liver diseases and conditions. Our multidisciplinary team works together to determine a detailed treatment plan your specific needs. We have one of the most successful liver transplant programs in the country and an exceptional hepatology program that offers innovative treatments for both infectious and noninfectious hepatic disorders.

Transplant recipients at the Allegheny Health Network Transplant Institute have experienced survival rates that are above the national average and among the best in the country, according to data from The Scientific Registry of Transplant Recipients (SRTR). The program also has the best three-year survival rate in the state, as well as the best one- and three-year patient outcomes in Pittsburgh.

Established in 2007, the Liver Transplant Program is approved by the United Network for Organ Sharing (UNOS), Medicare and Medicaid. The multidisciplinary team approach includes surgeons, hepatologists, gastroenterologists, transplant nurse coordinators, social workers, pharmacists and other health-care professionals. Our exceptional team of professionals collaborate consistently to develop a personalized treatment plan for you and provide high-quality, compassionate, patient-focused care. 

Allegheny Health Network is one of a select group of medical institutions in the country to have a program devoted solely to treating patients with liver cancer. The specialized teams offer innovative treatment options for patients with primary liver tumors, as well as those with disease that has metastasized to the liver from other parts of the body.

For instance, liver cancer patients have experienced great results from such treatments as embolization and chemoembolization, an injection of tiny particles – which may be soaked with chemotherapeutic agents – into the blood vessels that feed the tumor in order to stop blood flow to that part of the liver. Physicians also offer patients Yttrium-90 Radioembolization, an injection of tiny radioactive beads directly into the tumor bed of the liver.

One of the most exciting new advancements being pioneered at Allegheny Health Network to treat liver cancer is stereotactic body radiotherapy (SBRT). It’s a non-invasive radiation technique that precisely delivers high doses of radiation to isolated primary or metastatic liver tumors with minimal harm to surrounding healthy tissue. The patient the patient only has to undergo SBRT for five days, compared to two months of conventional radiation treatment and there are fewer side effects for the patient. Another significant use of SBRT is as a bridge to transplant and helping patients become eligible for transplantation by completely eliminating or shrinking the tumor with no harm to the liver prior to transplant.

Allegheny Health Network Transplant Institute: 412.359.6800
Erie residents: 855-625-4545